...
首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications
【24h】

Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications

机译:固体器官移植中非病毒特异性和病毒特异性T细胞应答的监测方法及其临床应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Opportunistic viral infections are still a major complication following solid organ transplantation. Immune monitoring may allow the identification of patients at risk of infection and, eventually, the modulation of immunosuppressive strategies. Immune monitoring can be performed using virus-specific and non virus-specific assays. This article describes and summarizes the pros and cons of the different technical approaches. Among the assays based on non virus-specific antigens, the enumeration of T-cell subsets, the quantification of cytokines and chemokines and the quantification of intracellular adenosine triphosphate following mitogen stimulation are described and their clinical applications to determine the risk for viral infection are discussed. In addition, current specific methods available for monitoring viralspecific T-cell responses are summarized, such as peptide-MHC multimer staining, intracellular cytokine staining, enzyme-linked immunospot and virus-specific IFN-gamma ELISA assays, and their clinical applications to determine the individual risk for opportunistic viral infections with human cytomegalovirus, Epstein-Barr virus and polyoma BK virus are discussed. The standardization of the procedure, the choice of the antigen(s) and the criteria to define cut-off values for positive responses are needed for some of these approaches before their implementation in the clinic. Nevertheless, immune monitoring combined with virological monitoring in transplant recipients is increasingly regarded as a helpful tool to identify patients at risk of infection as well as to assess treatment efficacy. (C) 2015 Published by Elsevier B.V.
机译:实体器官移植后,机会性病毒感染仍然是主要并发症。免疫监测可以识别有感染风险的患者,并最终调节免疫抑制策略。可以使用病毒特异性和非病毒特异性检测方法进行免疫监测。本文介绍并总结了不同技术方法的利弊。在基于非病毒特异性抗原的测定中,描述了T细胞亚群的计数,细胞分裂素和趋化因子的定量以及有丝分裂原刺激后细胞内三磷酸腺苷的定量,并讨论了其在确定病毒感染风险中的临床应用。此外,总结了目前可用于监测病毒特异性T细胞反应的特定方法,例如肽MHC多聚体染色,细胞内细胞因子染色,酶联免疫斑点和病毒特异性IFN-γELISA测定法,以及它们在临床中的应用。讨论了人类巨细胞病毒,爱泼斯坦-巴尔病毒和多瘤BK病毒机会性病毒感染的个体风险。这些方法中的一些在临床上实施之前,需要进行程序标准化,抗原选择和定义阳性反应临界值的标准。然而,在移植受体中将免疫监测与病毒学监测相结合越来越被认为是识别感染风险和评估治疗效果的有用工具。 (C)2015由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号